Related Experiment Video
Updated: Jun 29, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Racial and Ethnic Disparities in the Management of Chronic Coronary Disease
Wilson Lay Tang1, Fatima Rodriguez2
1Department of Medicine, Stanford University, 300 Pasteur Drive, L154, Stanford, CA 94305-5133, USA.
Insights
Racial and ethnic disparities significantly impact chronic coronary disease (CCD) care, affecting everything from lifestyle changes to invasive procedures. Addressing these inequities is vital for improving CCD management in diverse populations.
Area of Science:
- Cardiology
- Health Equity
- Clinical Trials
Background:
- Chronic coronary disease (CCD) encompasses a range of conditions, including obstructive and non-obstructive coronary artery disease.
- Existing evidence highlights significant racial and ethnic disparities in CCD clinical trials and management.
- These disparities span the full continuum of care, from lifestyle interventions to advanced procedures.
Purpose of the Study:
- To identify and analyze the pervasive racial and ethnic disparities in chronic coronary disease (CCD) guideline-informing clinical trials.
- To examine how these disparities affect the evidence-based management of CCD across its spectrum.
- To underscore the importance of addressing historical factors to improve CCD care equity.
Main Methods:
- Review of existing literature on racial and ethnic representation in CCD clinical trials.
- Analysis of disparities in CCD management strategies, including non-pharmacological, pharmacological, and procedural interventions.
- Examination of the impact of historical factors on current CCD care inequities.
Main Results:
- Racial and ethnic minorities are underrepresented in clinical trials informing CCD guidelines.
- Disparities are evident across all levels of CCD management, from lifestyle modifications to invasive cardiac procedures.
- Historical factors contribute significantly to the current inequitable landscape of CCD care.
Conclusions:
- Addressing racial and ethnic disparities is essential for advancing health equity in chronic coronary disease.
- A comprehensive understanding of historical factors is necessary to dismantle systemic barriers in CCD management.
- Improving representation and equity in CCD trials and care is critical for diverse patient populations.
Abstract:
Chronic coronary disease (CCD) comprises a continuum of conditions that include obstructive and non-obstructive coronary artery disease with or without prior acute coronary syndrome. Racial and ethnic representation disparities are pervasive in CCD guideline-informing clinical trials and evidence-based management. These disparities manifest across the entire spectrum of CCD management, spanning from non-pharmacological lifestyle changes to guideline-directed medical therapy, and cardiac rehabilitation to invasive procedures. Recognizing and addressing the historical factors underlying these disparities is crucial for enhancing the quality and equity of CCD management within an increasingly diverse population.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...